Pronounce: IM-e-TEL-stat
Classification: Telomerase Inhibitor
Imetelstat is a telomerase inhibitor. Telomerase inhibitors work by targeting the telomerase enzyme to stop uncontrolled cell division and do not grow. This is helpful in treating conditions like myelodysplastic syndrome (MDS).
Imetelstat is given intravenously (into a vein). The amount given and schedule are based on your size. You will have your labs checked before each dose. The results of your labs help guide your treatment plan. You will be given diphenhydramine (Benadryl) and hydrocortisone (steroid) before your infusion to help lessen an infusion-related reaction to the medication. Often, you will need to stay after your infusion is done to make sure you are not having a reaction.
There are many things you can do to manage the side effects of imetelstat. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your doctor or nurse know right away if you have a fever (temperature greater than 100.4°F/38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal. This medication can cause a rare complication called neutropenic colitis, which is a serious infection of the bowel. If you have abdominal pain, contact your care team immediately.
Tips to preventing infection:
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your oncology care team know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
Imetelstat can cause liver toxicity, which your oncology care team may monitor for using blood tests called liver function tests. Notify your healthcare provider if you notice yellowing of the skin or eyes, your urine appears dark or brown, or you have pain in your abdomen, as these can be signs of liver toxicity.
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
This medication can cause joint (arthralgia) or muscle (myalgia) aches and pains, which may be treated with medications. Talk with your care team about which pain relievers you can safely take. Non-medical therapies, such as acupuncture, yoga, gentle stretching, and exercise may also help reduce this side effect.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment and for at least 1 week after treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should consult with your healthcare team before breastfeeding while receiving this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania